MYGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Myriad Genetics Inc's other long-term assets for the quarter that ended in Sep. 2014 was $59.1 Mil.
Myriad Genetics Inc's quarterly other long-term assets increased from Mar. 2014 ($70.6 Mil) to Jun. 2014 ($92.3 Mil) but then declined from Jun. 2014 ($92.3 Mil) to Sep. 2014 ($59.1 Mil).
Myriad Genetics Inc's annual other long-term assets increased from Jun. 2012 ($171.3 Mil) to Jun. 2013 ($222.0 Mil) but then declined from Jun. 2013 ($222.0 Mil) to Jun. 2014 ($92.3 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
Myriad Genetics Inc Annual Data
|Other Long-Term Assets||4.9||4.5||3.9||92.0||77.6||96.6||96.7||171.3||222.0||92.3|
Myriad Genetics Inc Quarterly Data
|Other Long-Term Assets||171.3||170.9||162.6||184.1||222.0||222.4||201.2||70.6||92.3||59.1|